Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health
Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 10961-10976
DOI: 10.1111/dom.71180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 24.08.2026. Verfasst von Ann S Forrest und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Dyslipidemias, Cardiovascular Diseases, Renal Insufficiency, Chronic, Diabetic Nephropathies. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) and chronic kidney disease (CKD) frequently coexist and together create a ‘triple threat’ with dyslipidaemia, enhancing the risk for cardiovascular morbidity and mortality. Diabetic kidney disease (DKD) leads to altered lipid metabolism through insulin resistance, inflammation and oxidative stress resulting in an atherogenic lipid profile that accelerates atherosclerosis and vascular dysfunction. While statins remain the cornerstone of lipid‐lowering therapy, their cardiovascular benefits decline in advanced CKD. Combination therapy with ezetimibe and newer agents, including PCSK9 inhibitors and bempedoic acid, has shown further cardiovascular risk reduction in CKD. Emerging therapies targeting alternative pathways may address residual lipid abnormalities not corrected by traditional treatments but require longer‐term outcome data in people with DM and CKD. As the prevalence of both conditions rises, applying multifaceted lipid‐lowering strategies may yield the greatest reduction in cardiovascular events and improve survival among this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Virginia Commonwealth University, Richmond, Virginia, USA.
- Division of Endocrinology, Diabetes and Metabolism, Richmond VAMC, Richmond, Virginia, USA.
- Department of Endocrinology, Joslin Diabetes Center, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Ann S Forrest, Om P Ganda
Zitieren
APA
Forrest, A. S., Majety, P., Mayer, S. B., & Ganda, O. P. (2026). Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health. Diabetes, Obesity and Metabolism, 28(12), 10961-10976. https://doi.org/10.1111/dom.71180
Vancouver
Forrest AS, Majety P, Mayer SB, Ganda OP. Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health. Diabetes, Obesity and Metabolism. 2026;28(12):10961-10976. doi:10.1111/dom.71180
BibTeX
@article{Forrest2026,
author = {Forrest, Ann S and Majety, Priyanka and Mayer, Stéphanie B and Ganda, Om P},
title = {Dyslipidaemia, Chronic Kidney Disease and Diabetes Mellitus: A Triple Threat to Cardiovascular Health},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {12},
pages = {10961--10976},
doi = {10.1111/dom.71180}
}
EUVIMED